⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CATX News
Perspective Therapeutics, Inc.
Santhera Appoints Marc Clausse as Chief Commercial Officer to Lead Next Phase of Growth
globenewswire.com
CRSP
MRNA
BNTX
GSK
CATX
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
prnewswire.com
IBRX
NVCR
ONCY
NUVB
CATX
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
prnewswire.com
NVCR
IBRX
ONCY
CATX
NUVB
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
globenewswire.com
CATX
Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
CATX
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors
prnewswire.com
ONCY
RNXT
VSTM
PFE
CATX
Catalyx dévoile une solution de dégagement de ligne activée par l'IA afin de réduire les goulots d'étranglement dans les sciences de la vie USA - Français USA - English USA - English USA - español USA - Deutsch
prnewswire.com
CATX
Catalyx Unveils AI-Powered Line Clearance Solution to Reduce Manufacturing Bottlenecks in Life Sciences USA - English USA - English
prnewswire.com
CATX
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
CATX
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
globenewswire.com
CATX